Increasing evidence suggests that myeloid cell programing, iNOS, and Arg1 contribute to the pathogenesis of numerous virus infections, suggesting that therapies that target these cells and pathways may be beneficial for the treatment of some virus diseases. The gene discussed is ARG1; the disease is viral infectious disease.